Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-24-003916
Filing Date
2024-11-14
Accepted
2024-11-14 19:15:12
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS II LLC

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G 65173
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 6126
  Complete submission text file 0000929638-24-003916.txt   72987
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Subject) CIK: 0001722926 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91181 | Film No.: 241465170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

EIN.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G